Pegylated Liposomal Doxorubicin in Combination with Hyperthermia in the Treatment of a Case of Advanced Hepatocellular Carcinoma
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F02%3A00001066" target="_blank" >RIV/00216208:11150/02:00001066 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pegylated Liposomal Doxorubicin in Combination with Hyperthermia in the Treatment of a Case of Advanced Hepatocellular Carcinoma
Original language description
This may be the first report of the combination of pegylated liposomal doxorubicin (PLD, Caelyx) and hyperthermia in the treatment of advanced hepatocellular carcinoma. Our observation suggests that the combination of PLD with hyperthremia is technicallyfeasible, well tolerated, and could have synergistic potential.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2002
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Clinical Gastroenterology
ISSN
0192-0790
e-ISSN
—
Volume of the periodical
34
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
2
Pages from-to
96-98
UT code for WoS article
—
EID of the result in the Scopus database
—